A Randomised Study Comparing Granulocyte-colony Stimulating Factor (G-CSF) with G-CSF Plus Thymostimulin in the Treatment of Haematological Toxicity in Patients with Advanced Breast Cancer after High Dose Mitoxantrone Therapy

By Sanchiz F.   Milla A.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 52-56

Elsevier

Access to resources Recommend Favorite

A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia

By Lalami Y.   Paesmans M.  

Supportive Care in Cancer, Vol. 12, Iss. 10, 2004-10 ,pp. : 725-730

Springer Publishing Company

Access to resources Recommend Favorite

Increasing the Dose Intensity of Chemotherapy by Means of Granulocyte-colony Stimulating Factor (G-CSF) Support in the Treatment of Small Cell Lung Cancer (SCLC)

By Girling D.J.   Thatcher N.   Clark P.I.   Stephens R.J.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1263-1263

Elsevier

Access to resources Recommend Favorite

The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia

By Haim Nissim   Shulman Katerina   Goldberg Hadassah   Tsalic Medy  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 229-232

Humana Press, Inc

Access to resources Recommend Favorite

Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patients

By Rajan Suja   Stearns Sally   Lyman Gary   Carpenter William  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 255-266

Springer Publishing Company

Access to resources Recommend Favorite